Results 201 to 210 of about 2,753,395 (319)

Mechanical Cell Reprogramming on Tissue-Mimicking Hydrogels for Cancer Cell Transdifferentiation. [PDF]

Research (Wash D C)
Ren X, Wang Y, Lei M, Zou Y, Li P, Qi F, Shi J, Xie H, Zhang M, Wang W, Xue L, Chen P, Liu BF, Li Y.   +13 more
europepmc   +1 more source

STUDIES ON Zn65 UPTAKE BY EHRLICH ASCITES CANCER CELLS IN VITRO

, 1966
SHYUNICHI FUJII
openalex   +2 more sources

Effect of adriamycin and high-dose methotrexate chemotherapy onin vivo andin vitro cell-mediated immunity in cancer patients [PDF]

, 1978
Jack A. Roth, Frederick R. Eilber, Donald L. Morton   +2 more
openalex   +1 more source

Multi‐omic profiling of squamous cell lung cancer identifies metabolites and related genes associated with squamous cell carcinoma

Molecular Oncology, EarlyView.
Using multi‐omic characterization, we aimed to identify key regulators specific to squamous cell lung carcinoma (SqCC). SqCC‐specific differentially expressed genes were integrated with metabolics data. High expression of the creatine transporter SLC6A8, along with elevated creatine levels, appeared to be a distinct metabolic feature of SqCC.
Johan Staaf, Daniel Ehinger, Hans Brunnström, Mats Jönsson, Frida Rosengren, Marija Kotevska, Anna Karlsson, Mattias Aine, Christian Frezza, Maria Planck, Elsa Arbajian   +10 more
wiley   +1 more source

Single-cell analyses EMP1 as a marker of the ratio of M1/M2 macrophages is associated with EMT, immune infiltration, and prognosis in bladder cancer

, 1970
Jinqiao Li, Jianyu Liu, Honglei Wang, Jinpeng Ma, Yueze Wang, Wanhai Xu   +5 more
openalex   +1 more source

Changes in the structuredness of cytoplasmic matrix (SCM) in human lymphocytes induced by PHA and cancer basic protein as measured in single cells [PDF]

, 1976
Lea Čerček, Bojan Cercek
openalex   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Targeting cancer cell stiffness and metastasis with clinical therapeutics. [PDF]

Clin Exp Metastasis
Gajda AM, Rodríguez-López R, Er EE.
europepmc   +1 more source

Cell cycle changes in ovarian cancer after arabinosylcytosine [PDF]

, 1974
Patrick F. Sheehy, Jerrold Fried, Rodger J. Winn, Bayard D. Clarkson   +3 more
openalex   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source